sorry, we can't preview this file
...but you can still download supplementary material.docx
supplementary material.docx (87.37 kB)
Cost–effectiveness of adjuvant atezolizumab for patients with stage II–IIIA PD-L1+ non-small-cell lung cancer. Supplementary material
dataset
posted on 2023-04-06, 11:36 authored by Janet S Lee, Jan Bhagwakar, Caroline Nguyen, Ann Johnson, Nick Jovanoski, Sarika Ogale, Millie DasSupplementary data
